Drug profile · INN
cefazolin sodium
CEFAZOLIN SODIUM
cefazolin sodium (CEFAZOLIN SODIUM) is a bacterial penicillin-binding protein inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Drug details — cefazolin sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
cefazolin sodium (CEFAZOLIN SODIUM) is a bacterial penicillin-binding protein inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial penicillin-binding protein inhibitor
Primary target: Bacterial penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is cefazolin sodium?
cefazolin sodium (CEFAZOLIN SODIUM) is a bacterial penicillin-binding protein inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for cefazolin sodium?
CEFAZOLIN SODIUM is a marketed brand name for cefazolin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cefazolin sodium?
cefazolin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.